Captopril formulation providing increased duration of activity

Details Captopril formulation providing increased duration of activity Captopril formulation providing increased duration of activity

1991-08-16

1992-10-27

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424461, 424462, 424469, 424471, 424480, 424482, 424494, 424495, 424497, 518929, A61K 31195, A61K 924, A61K 926, A61K 956

Patent

active

051587777

ABSTRACT:
A formulation comprising captopril within an enteric or delayed release coated pH stable core combined with additional captopril that is available for immediate release following administration.

REFERENCES:
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4666705 (1987-05-01), De Crosta et al.
patent: 4728512 (1988-03-01), Mehta et al.
patent: 4756911 (1988-07-01), Drost et al.
patent: 4794001 (1988-12-01), Mehta et al.
patent: 4800084 (1989-01-01), Zerbe
patent: 4808413 (1989-02-01), Joshi et al.
patent: 4814178 (1989-03-01), Bolton et al.
patent: 4814179 (1989-03-01), Bolton et al.
patent: 4851228 (1989-07-01), Zentner et al.
patent: 4910021 (1990-03-01), Davis et al.
Translation Japanese Patent Application No. 61-36217.
Physicians Desk Reference, 44th Edition, pp. 2129-2135.
FMC, "Preparation Of Avicel Spheres Using Several Methods of Manufacture", 1985.
Rohm Pharma, "Eudragit L and S".
Morflex, "Citrate Esters As Plasticizers For Aqueous Based Pharmaceutical Coatings".
Kodak, "Eastman HPMCP Enteric Coating Material (Hydroxypropyl Methylcellulose Phthalate)".
Kodak, "Eastman Cellulose Acetate Trimellitate (GA-T) Enteric Coating Material".
Kodak, "Eastman C-A-P Enteric Coating Material".
Hu et al., "Passive and Carrier-Medicated . . . " Jour. of Pharmaceutical Sciences, vol. 77, 1007-1011 (1988).

Affiliated with

Also associated with

Rating

Captopril formulation providing increased duration of activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Captopril formulation providing increased duration of activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Captopril formulation providing increased duration of activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-904516